Insiders Bio-Techne Corporation

Equities

Market Closed - Nasdaq Other stock markets 16:00:00 2024-05-09 EDT			5-day change	1st Jan Change
79.63 ^USD	+3.35%		+5.33%	+3.20%

05-06	Argus Adjusts Price Target on Bio-Techne to $95 From $90, Keeps Buy Rating	MT
05-02	UBS Adjusts Price Target on Bio-Techne to $90 From $80, Maintains Buy Rating	MT

Bio-Techne Corporation Appoints Dr. Judith Klimovsky to Board of Directors	04-30	CI
Bio-Techne Corporation Appoints Kim Kelderman as Chief Executive Officer Effective February 1, 2024	01-05	CI
Bio-Techne Corporation Appoints Matthew F. Mcmanus as President, Diagnostics and Genomics Segment, Effective January 8, 2024	01-05	CI
Bio-Techne Says CEO Chuck Kummeth to Retire, Names Kim Kelderman Successor	23-10-19	MT
Bio-Techne Corporation Announces Executive Changes	23-10-19	CI
Bio-Techne Corporation Announces Chief Executive Officer Changes	23-10-19	CI
Tekcapital's portfolio company seals joint venture	23-09-19	AN
Bio-techne Director Nusse Sells 8,939 Shares for $717,959	23-09-01	MT
Insider Sell: Bio-techne	23-07-25	MT
Bio-Techne Corporation Announces Executive Changes, Effective March 3, 2023	23-01-31	CI
Insider Sell: Bio-techne	22-12-09	MT
Credit Suisse Initiates Coverage of 20 Companies in Life Science Tools, Services, Diagnostics Sectors; Outperform-Rated Bio-Rad, IQVIA, Bipo-Techne, Natera Named Top Picks	22-08-25	MT
Insider Sell: Bio-techne	22-08-12	MT
Bio-Techne Fiscal Q4 Adjusted Earnings, Sales Rise; CEO Chuck Kummeth to Retire in 2024	22-08-04	MT
Bio-Techne Corporation Announces CEO Transition Plan	22-08-04	CI
Insider Sell: Bio-techne	22-06-09	MT
Insider Buy: Bio-Techne	22-05-11	MT
Bio-Techne Corporation Announces Appointment of Brenda Everson as Senior Vice President, Human Resources Effective January 10, 2022	21-12-27	CI
Bio-Techne Corporation Announces Executive Changes	21-12-21	CI
Insider Sell: Bio-Techne	21-11-16	MT

No results for this search